Advanced SearchSearch Tips
Evaluation of Sustained-release Dosage Form with Novel Metformin Salts
facebook(new window)  Pirnt(new window) E-mail(new window) Excel Download
 Title & Authors
Evaluation of Sustained-release Dosage Form with Novel Metformin Salts
Kim, Dong-Wook;
  PDF(new window)
In this study, metformin hydrochloride for first choice of type 2 diabetes patient is administered relatively high dose, 1000 to 2000 mg orally once a day, and had very high water solubility, so it make difficult to swallow tablet to requires high amount of sustained release agent. To overcome these challenges, we used novel metformin salts had relatively low water solubility to minimize sustaining excipient for small size of dosage form. six novel metformin salts were synthesized by making metformin free form under reaction with NaOH and adding acid salts. we confirmed metformin stearate had the lowest water solubility and showed half drug release in dissolution study at 12hour. In conclusion, novel metformin salts had low water solubility can be used to reduce the size of sustained metformin tablet for improving patient compliance.
Metformin;Salt;Solubility;Sustained release;
 Cited by
M. Rendell, Diabetes "New drug options and old choices", Consultant, Vol. 53, pp. 217-227, April, 2013.

M. Ashiya, E. Richard, T. Smith, "Non-insulin therapies for type 2 diabetes", Nature Reviews Drug Discovery, Vol. 6, pp. 777-778, 2007. DOI: crossref(new window)

S. M. Setter, J. L. Iltz, J. Thams, R. K. Campbell, "Metformin hydrochloride in the treatment of type 2 diabetes mellitus: A clinical review with a focus on dual therapy", Clinical Therapeutics, Vol. 25(12), pp. 991-3026, 2003. DOI:

G. G. Graham, J. Punt, M. Arora, R. O. Day, P. M. Doogue, J. Duong, J. T. Furlong, J. R. Greenfield, L. C. Greenup, C. M. Kirkpatrick, J. E. Ray, P. Timmins, M. K. Williams, "Clinical Pharmacokinetics of Metformin", Clinical Pharmacokinetics, Vol. 50(2), pp. 81-98, 2011. DOI: crossref(new window)

P. H. Marathe, Y. Wen, J. Norton, D.S. Greene, R.H. Barbhaiya, I.R. Wilding, "Effect of altered gastric emptying and gastrointestinal motility on metformin absorption", Clinical Pharmacology, Vol. 50, pp. 325-332, 2000. DOI:

D. Stepensky, M. Friedman, W. Srour, I. Raz, A. Hoffman, "Preclinical evaluation of pharmacokinetic pharmacodynamic rationale for oral CR metformin formulation", Journal of Controlled Release, Vol. 71, pp. 107-115, 2001. DOI: crossref(new window)

U. K. Kotreka, M. C. Adeyeye, "Gastroretentive floating drug delivery system : a critical review", Critical Reviews in Therapeutic Drug Carrier Systems, Vol. 28(1), pp. 47-99, 2011. DOI: Syst. v28.i1.20 crossref(new window)

S. Arora, J. Ali, A. Ahuja, R. K. Khar, S. Baboota, "Floating Drug Delivery Systems: A Review", AAPS PharmSciTech., Vol. 6(3), pp. 372-390, 2005. DOI: crossref(new window)

M. Rajab, M. Jouma, R. H. Neubert, M. Dittgen, "Influence of water-soluble polymers on the in vitro performance of floating mucoadhesive tablets containing metformin", Drug Development and Industrial Pharmacy, Vol. 40(7) pp. 879-85, 2014. DOI:

M. Rajab, M. Jouma, R. H. Neubert, M. Dittgen, "Optimization of a metformin effervescent floating tablet containing hydroxypropylmethylcellulose and stearic acid", Pharmazie, Vol. 65(2), pp. 97-101, 2010.

S. M. Berge, L. D. Bighley, D. C. Monkhouse, "Pharmaceutical salts", Journal of Pharmaceutical Science, Vol. 66(1), pp. 1-19, 1977. DOI: crossref(new window)

P. H. Stahl, C. G. Wermuth, "Handbook of Pharmaceutical Salts: Properties, Selection and Use", Weinheim/Zurich:Wiley-VCH/VHCA, 2002.

J. B. Nanubolu, B. Sridhar, K. Ravikumar,, K. D. Sawant, T. A. Naik, L. N. Patkar, S. Cherukuvadac, B. Sreedhard, "Polymorphism in metformin embonate salt - recurrence of dimeric and tetrameric guanidinium? carboxylate synthons" Crystal Engineering Community, Vol. 15, pp. 4448-4464, 2013. DOI: crossref(new window)

P. Timmins, W.J. Winter, S. K. Srivastava, A.E. Bretnall, C. Wei, G.L. Powers, "Salts of metformin and methods", US Patent 6,031,004, 2000.

R.C. Rowe, P. J. Sheskey, S.C. Owen, "Handbook of Pharmaceutical Excipients, 5th ed." Pharmaceutical Press, 2006.

L. C. Block, L. O. Schmeling, A. G. Couto, M. A. S. Silva, M. P. Tagliari, T. M. B. Bresolin, S. C. Mourao, "Effect of binders on 500mg metformin hydrochloride tablets produced by wet granulation", Journal of Basic and Applied Pharmaceutical Sciences, Vol. 30(2), pp. 145-152, 2009.

P. Timmins, A. B. Dennis, K. A. Vyas, "Biphasic controlled release delivery system for high solubility pharmaceutical and method", US Patent 6,475,521, 2002.

J. W. Kamlesh, B. K. Rajendra, J. U. Milind, "Study on sustained-release metformin hydrochloride from matrix tablet: Influence of hydrophilic polymers and in vitro evaluation", International Journal Pharmaceutical Investigation, Vol. 1(3) pp. 157-163, 2011. DOI: crossref(new window)

H. G. Brittain "Analytical Profiles of Drug Substances and Excipients" Vol. 25, pp. 243-293, 1998. DOI:

A. J. Wagstaff, D. P. Figgitt "Extended-release metformin hydrochloride. Single-composition osmotic tablet formulation" Treat Endocrinol. Vol. 3(5) pp. 327-32, 2004. DOI: crossref(new window)